Cargando…
Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab
Hepatocellular carcinoma (HCC) is an aggressive liver tumor that occurs with chronic liver disease. Surgical resection is the mainstay of therapy for localized disease whereas therapeutic options for advanced disease are limited. The innovative blockade of immune checkpoints with targeted immunother...
Autores principales: | Truong, Phu, Rahal, Ahmad, Kallail, K. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934853/ https://www.ncbi.nlm.nih.gov/pubmed/27433410 http://dx.doi.org/10.7759/cureus.631 |
Ejemplares similares
-
Beyond the Expectation: Pembrolizumab-Associated Tumor Lysis Syndrome in Metastatic Gastric Adenocarcinoma
por: Battah, Arwa, et al.
Publicado: (2023) -
A Case of Advanced Multifocal Cholangiocarcinoma With Excellent Response to Pembrolizumab
por: Habib, Tehmina, et al.
Publicado: (2023) -
Oxaliplatin-Induced Tonic-Clonic Seizures
por: Rahal, Ahmad K., et al.
Publicado: (2015) -
Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020) -
Extrahepatic Vascular Parasitization by a Hepatocellular Carcinoma
por: Ertreo, Marco, et al.
Publicado: (2019)